Company Introduction :

Manufacturer of pharmaceutical ingredient and intermediates. The Chlorzoxazone passed the US FDA inspection in 1995. Again, the Diclofenac sodium, Diclofenac potassium and Chlorzoxazone passed the US FDA inspection in 1999. Diltiazem HCl filed US DMF in 2000. And some products filed European DMF and Canadian DMF. OHSAS 18000 approved and Taiwan GMP inspection passed.

Main Products :

medicine manufacturer exporter, medicine manufacturer exporter, generic drug company, generic drug companies, drug maker, drug makers, bulk drug, bulk pharmaceutical, generic drug, medicine, pharmaceutical raw materials- Atenolol, Bromhexine HCl, Chlormezanone, Chlorzoxazone, active pharmaceutical ingredients, Clofibrate, Cloperastine HCl, Crotamiton, Diclofenac Diethylamine, Diclofenac Potassium, Diclofenac Sodium, Diltiazem HCl, Eperisone HCl, Etofibrate, Metoprolol Tartrate, Metoprolol Succinate, Lidocaine HCL, Lidocaine Base, Nicametate Citrate, Orciprenaline Sulfate, Oxazolam, Oxethazaine ( Oxetacaine), Pramoxine HCl, Phenyltoloxamine Citrate, Phenylephrine HCl, Pipethanate HCl, Sulcaine, D-Timolol Maleate, L Timolol Maleate, Tolperisone HCl, Econazole Nitrate, Famotidine, Lovastatin, Norfloxacin, Povidone Iodine, Theophylline Sodium Glycinate, Sodium Stearyl Fumarate, Prazosin HCL, Fusidie Acid & Na.

Other Information :

Business Nature :	Manufacturer
Company Capital :	USD 8,000,001 ~ 10,000,000
Annual Revenue :	USD 8,000,001 ~ 10,000,000
President :	Mr. C.T Fan
No. of Total Staff :	1 ~ 50
Current Export Markets :	Worldwide
Brand Names :	SYN-TECH
Trade Term :	CIF
Shipment :	Sea, Air
Currency :	USD
Negotiable :	Negotiable